Overview of inclusion and exclusion criteria of RCTs testing for RCTs testing other single treatments. (XLSX 17Â kb)

NIAID Data Ecosystem40

Dataset from A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, 4-week Study to Evaluate the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Repeat Inhaled Doses of the Combination of GSK233705 and GW642444 Administered Once-daily in Subjects With COPD

COPD临床试验

吸入药物组合安全性

The purpose of this study is the evaluate the safety and tolerability of repeat dosing of the combination of inhaled GSK233705 and GW642444 administered once-daily in subjects with COPD.

NIAID Data Ecosystem30

Dataset from A Randomised, Single-dose, Dose Ascending, Double-blind, Placebo Controlled, Four-way, Incomplete Block Crossover Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Inhaled Doses of GW642444M With Magnesium Stearate in COPD Patients.

COPD临床试验

吸入型支气管扩张剂药理学

This study will involve the use of a new compound, GW642444 that is being developed for the treatment of asthma and chronic obstructive pulmonary disease (COPD). It works by acting on cells in the lun

NIAID Data Ecosystem20

Additional file 5: Table S10. of Eligibility of real-life patients with COPD for inclusion in trials of inhaled long-acting bronchodilator therapy

资源简介：

Additional file 5: Table S10. of Eligibility of real-life patients with COPD for inclusion in trials of inhaled long-acting bronchodilator therapy

资源简介：

相关数据集